OVID THERAPEUTICS INC (OVID) Stock Income Statement
NASDAQ:OVID - Nasdaq - US6904691010 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 548.00K | 566.00K | 391.70K | 1.50M | 208.40M | |||
| Operating Expenses | 57.56M | 62.45M | 59.67M | 57.10M | 84.20M | |||
| Research and Development | 33.02M | 36.77M | 28.59M | 24.60M | 46.90M | |||
| Selling, General, and Administrative Expenses | 24.54M | 25.68M | 31.09M | 32.40M | 37.20M | |||
| Operating Income | -57.02M | -61.88M | -59.28M | -55.50M | 124.20M | |||
| Interest Income/Expense | 2.04M | 5.45M | 6.94M | 1.40M | 0.00 | |||
| Other Income/Expense | N/A | 30.00M | N/A | -500.00K | N/A | |||
| Income Before Taxes | -24.97M | -26.43M | -52.34M | -54.20M | 124.20M | |||
| Income Tax | 0.00 | 0.00 | N/A | 0.00 | 1.30M | |||
| Net Income | -24.97M | -26.43M | -52.34M | -54.20M | 119.80M | |||
| EBITDA | -56.40M | -61.27M | -58.71M | -55.00M | 124.40M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.35 | -0.37 | -0.74 | -0.77 | 1.76 | |||
| Non GAAP EPS | -0.35 | -0.38 | -0.75 | -0.77 | 2.03 | |||
| Statistics | ||||||||
| Profit Margin | -4557.12% | -4670.14% | -13362.01% | -3613.33% | 57.49% | |||
| Operating Profit Margin | -10404.20% | -10933.75% | -15134.41% | -3700.00% | 59.60% | |||
All data in USD